Calithera Biosciences Inc (CALA)

5.71 -0.10  -1.72% NASDAQ May 29, 14:33 Delayed 2m USD

Calithera Biosciences Cash from Financing (Quarterly):

7.659M for March 31, 2020
View 4,000+ financial data types
View Full Chart

Cash from Financing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (Quarterly) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 7.659M
Dec. 31, 2019 42.02M
Sept. 30, 2019 -0.247M
June 30, 2019 55.98M
March 31, 2019 1.154M
Dec. 31, 2018 8.406M
Sept. 30, 2018 5.692M
June 30, 2018 0.378M
March 31, 2018 0.15M
Dec. 31, 2017 1.768M
Sept. 30, 2017 0.223M
June 30, 2017 0.378M
March 31, 2017 120.58M
Dec. 31, 2016 4.561M
Sept. 30, 2016 3.085M
June 30, 2016 -0.073M
March 31, 2016 4.243M
Dec. 31, 2015 0.30M
Sept. 30, 2015 0.262M
June 30, 2015 0.276M
March 31, 2015 0.007M
Dec. 31, 2014 71.66M
Sept. 30, 2014 13.06M
June 30, 2014 3.128M
March 31, 2014 0.017M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Benchmarks

Athersys Inc 10.10M
Arcus Biosciences Inc 0.61M
MediciNova Inc 0.4189M

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum -0.247M Sep 2019
Maximum 120.58M Mar 2017
Average 12.84M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.